Health Law Diagnosed — Transactions Part 2: The Role Of Health Regulatory Diligence And How To Prepare For A Sell-Side Transaction (Podcast)

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Explore Firm Details

Health regulatory diligence has the ability to make or break a deal.

United States Food, Drugs, Healthcare, Life Sciences

Tara E. Dwyer,Xavier G. Hardy,Lauren M. Moldawer

+3 Authors

Your Author LinkedIn Connections

Article Insights

Tara E. Dwyer’s articles from Mintz are most popular:

with readers working within the Media & Information and Pharmaceuticals & BioTech industries

Mintz are most popular:

within Law Practice Management and Coronavirus (COVID-19) topic(s)

selfHealth Law Diagnosed · Transactions Part 2: Health Regulatory Diligence and How to Prepare for a Sell-Side Transaction

Health regulatory diligence has the ability to make or break a deal. Listen to hear about our team's firsthand experience in the importance of conducting health regulatory diligence and best practices in preparing for a sell-side transaction.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Authors